The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease
Abstract
Bacteria constitute about 90% of all cells in the human body. The densest and most complex bacterial community is in the large intestine. This population is quite stable in healthy intestines, but intestinal disease distorts the ecological balance and induces dysbiosis. Results of studies have indicated that the epithelial and metabolic changes that occur with colorectal cancer provide a competitive advantage to a subset of intestinal bacteria. Strikingly, however, Streptococcus gallolyticus gallolyticus (previously known as Streptococcus bovis biotype I) is one of the very few opportunistic pathogens that has been clinically linked to colonic malignant diseases. In this Personal View we describe how S. gallolyticus gallolyticus exploits its unique range of virulence features to cause infections in patients with colorectal cancer. We postulate that distinct virulence factors on one hand enable this bacterium to establish a symptomatic infection in susceptible individuals, and on the other hand make its ability to do this dependent on pre-existing colonic abnormalities. We believe that our current reconstruction of this route of infection aids understanding of how S. gallolyticus gallolyticus infections can be best exploited for early detection of colorectal cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The epithelial and metabolic changes that occur during development of CRC might provide a competitive advantage to a subset of intestinal bacteria.185”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [185]
In the citing paper
“a small number of specific pathobionts have now been linked with adenomas and CRC including Streptococcus gallolyticus,94 Enterococcus faecalis95 and B. fragilis.84”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [94]
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. C. (2008) · Nature · doi:10.1038/nature07602 · Cited by 2,232
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,685
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
Willett, W. C., Stampfer, M. J., Colditz, G. A., ROSNER, B. A., & Speizer, F. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012133232404 · Cited by 1,239
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshitá, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 965
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903
Self-citation
Cited by
Sorted by citations
Items 101–158 of 158
Immunomodulatory Effects of Flavonoids in Colitis-Associated Colorectal Cancer
Navia, S. E. H., Vega, L., Rodríguez, T., & Rodríguez‐Sosa, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041883 · Cited by 7
Kambarev, S., Pecorari, F., & Corvec, S. (2017) · Genome Announcements · doi:10.1128/genomea.00226-17 · Cited by 8
Identification of the Microbiota in the Aging Process
Sarkar, A., & Pitchumoni, C. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00004-5 · Cited by 8
Martins, M., du Merle, L., Trieu‐Cuot, P., & Dramsi, S. (2019) · Microbes and Infection · doi:10.1016/j.micinf.2019.12.001 · Cited by 7
Firuzi, P., Hashemi, A. A., Kafil, H. S., Gholizadeh, P., & Aslani, H. (2020) · Environmental Monitoring and Assessment · doi:10.1007/s10661-020-08470-4 · Cited by 7
Modarres, M. P., Habibi, M. A., Pashaei, M. R., Mohammadpour, Y., Jazi, K., & Ahmadpour, S. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947270529231116114913 · Cited by 6
Müller‐Werdan, U., & Werdan, K. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0084 · Cited by 6
Luévano, J. M., Liu, J. C., & Stappenbeck, T. S. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000864 · Cited by 6
Yang, X., Zhang, K., Xia, L., & Li, J. (2026) · iMetaMed · doi:10.1002/imm3.70030 · Cited by 5
The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer
Corredoira, J., Míguez, E., Mateo, L. M., Fernández-Rodríguez, R., García-Rodríguez, J. F., Pérez‐González, A., Sanjurjo, A., Pulian, M. V., Ayuso-García, B., In behalf all members of GESBOGA group, et al. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04618-5 · Cited by 5
The Intestinal Microbiome in Humans: Its Role for a Healthy Life and in the Onset of Diseases
Gașpar, B. S., Profir, M., Roşu, O. A., Ionescu, R. F., & Creţoiu, S. M. (2024) · Physiology · doi:10.5772/intechopen.113719 · Cited by 5
Søgaard, K. K., Veres, K., Vandenbroucke‐Grauls, C. M. J. E., Vandenbroucke, J. P., Sørensen, H. T., & Schønheyder, H. C. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0705 · Cited by 5
Epigenetics and the role of nutraceuticals in health and disease
El-Sayed, A., Aleya, L., & Kamel, M. S. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-25236-w · Cited by 6
Growth rate alterations of human colorectal cancer cells by 157 gut bacteriaPreprint
Taddese, R., Garza, D. R., Ruiter, L. N., de Jonge, M. I., Belzer, C., Aalvink, S., Nagtegaal, I. D., Dutilh, B. E., & Boleij, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.14.876367 · Cited by 5
Self-citationIntratumoral microbiota in cancer: molecular mechanism and therapeutic strategies
Yu, Y., Guo, Z., Luo, Z., Dian, Y., Yang, X., Chen, X., Zeng, F., & Deng, G. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00473-w · Cited by 4
Malignancy and Endocarditis: Divulging Into the Intertwined Association
Pugalenthi, L. S., Ahmad, M., Reddy, S., Barkhane, Z., Elmadi, J., & Kumar, L. S. (2022) · Cureus · doi:10.7759/cureus.24089 · Cited by 4
Rifino, N., Sangalli, D., Tagliabue, F., Basilico, P., Filizzolo, M. G., Riva, B., & Salmaggi, A. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03996-z · Cited by 4
Importance of Gut Microbiome-Based Therapeutics in Cancer Treatment
Bazaz, M. R., Rahman, Z., Qadir, I., Pasam, T., & Dandekar, M. P. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_24 · Cited by 3
Sánchez, J. C., García, B. A., Lema, E. M. R., García-Pais, M. J., Rodríguez-Macias, A. I., González, P. C., López, R. O., Rey, R. R., & García, P. A. (2023) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.06.019 · Cited by 3
Geese as reservoirs of human colon cancer-associated Streptococcus gallolyticus
Cagri, M. A., ŞAHİN, M., Ersoy, Y., Altuntaş, C. A., & BÜYÜK, F. (2024) · Research in Veterinary Science · doi:10.1016/j.rvsc.2024.105341 · Cited by 3
Streptococcus gallolyticus subsp. gallolyticus pathogenesis: current state of play
Grimm, I., & Vollmer, T. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0053 · Cited by 3
Streptococcus gallolyticus and its implication in colorectal cancer
Pardo, C. P., Gonzalez, R. C., Pinto, E. S., & Galiana, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00003-9 · Cited by 2
Méndez-Hirata, G., Rivera‐Buendía, F., Viveros-Rentería, E., Ochoa‐Hein, E., Cornejo‐Juárez, P., Márquez, M. F., Hidalgo-Dura, J. R., Leyva-López, Y., & Vilar‐Compte, D. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.103123 · Cited by 2
Theoretical analysis of the intestinal microbiota influence on colorectal cancer development
Tiuliukin, I. O., & Ivanchov, P. V. (2024) · Inter Collegas · doi:10.35339/ic.11.3.tiv · Cited by 3
Shastry, R. P., Hameed, A., Banerjee, S., Prabhu, A., Bajire, S. K., Pavan, S. R., Dhanyashree, H. R., Kotimoole, C. N., Stothard, P., Surya, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-94666-y · Cited by 3
Niger, C. L., Dalbies, F., Narbonne, V., Héry-Arnaud, G., Virmaux, M., Leostic, C., Hervé, F., & Liétard, C. (2014) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2014.05.001 · Cited by 2
Maciejewska, A., Ługowski, C., & Łukasiewicz, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911797 · Cited by 2
Almeida, A. S., Tran, T. T. T., Ghosh, T. S., Ribière, C., Foley, C., Azevedo, L. A., Pellanda, P., Frei, W., Hueston, C. M., Kumar, R. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.24.432654 · Cited by 2
Sánchez, J. C., García, B. A., Lema, E. M. R., García-Pais, M. J., Rodríguez-Macias, A. I., González, P. C., López, R. O., Rey, R. R., & García, P. A. (2022) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2022.06.010 · Cited by 1
Ung, W., & Bonavida, B. (2025) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2025058249 · Cited by 1
Zhang, X., Sun, S., Cheng, S., Dai, J., Du, F., Wang, J., Wei, D., Yan, Y., & Liu, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1601688 · Cited by 1
Recent advances in the research of sarcopenia in colorectal cancer
Wang, Y., Wang, Y., & Liu, M. R. (2025) · Holistic Integrative Oncology · doi:10.1007/s44178-025-00210-3 · Cited by 1
Liu, S., Wang, J., Dong, S., Duan, Y., & Ma, Y. (2026) · Journal of Animal Science · doi:10.1093/jas/skag012 · Cited by 1
Ayanoglu, E., Tavşanlı, H., & Çıbık, R. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71489 · Cited by 1
Salehi, M., Gottardo, A., Russo, T. D. B., Bonventre, G., Incorvaia, L., Gristina, V., Trecciola, M. C., & Galvano, A. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105416 · Cited by 1
Gut microbial metabolites and colorectal cancer
Masood, M., & Nasser, M. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99476-7.00011-9 · Cited by 1
Huang, X., Li, H., Cheng, F., Wang, L., Cao, G., Wang, L., & Shi, L. (2023) · Animal Research and One Health · doi:10.1002/aro2.39 · Cited by 1
Zhou, X., Zhao, Y., Zhao, R., Shafi, S., Yang, Y., Liu, G., & Liu, S. (2024) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.178 · Cited by 1
Shanti, I., Samardali, M., & Gebremedhen, A. I. (2024) · Cureus · doi:10.7759/cureus.74264 · Cited by 1
Vilardell, P., Moral, S., Frigola, J. M., Morales, M., Ballesteros, E., Salgado, X., Castro, A., Rubió, A., Abulí, M., & Brugada, R. (2021) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2021.88.96 · Cited by 1
Association between Streptococcus gallolyticus and Colorectal Cancer in Egyptian Patients
Tabl, H., Zidan, A., Elfeky, H. M., & El-Fattah, G. A. (2019) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2019.283032 · Cited by 1
Ghoddusi, H. B., & Thomas, L. V. (2017) · Wiley eBooks · doi:10.1002/9781119214137.ch1 · Cited by 1
Bacteremia and colon cancer: Causality or coincidence?
Corredoira, J., & Ayuso, B. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.02.012 · Cited by 1
Araújo, A. F. G. D., & Teixeira, L. N. (2021) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2019.7602
Bescucci, D. M. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-ytng-wt48
Bacteremia and colon cancer: Causality or coincidence?
Corredoira, J., & Ayuso, B. (2022) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2022.02.003
Zhang, N., Bai, Z., Wang, S., Mao, Y., Chen, L., Huang, B., Cheng, Z., Wang, X., & Han, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1963694/v1
A comparative study of gut microbiota in the healthy elderly and the elderly with colorectal cancer
Iadsee, N. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.246
Impact du microbiote intestinal dans les cancers colorectaux
Fidelle, M., Chen, J., Roberti, M. P., Kroemer, G., & Zitvogel, L. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.09.009
Other Gram-Positive Infections
Tatara, A. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-39474-4_3
Microbiome-Based Therapeutics for the Management of Cancer
Munir, M. U., Javed, I., Butt, M. H., Khan, Y. H., Salman, M., Rehman, Z. U., Khan, F. U., Shamsi, S. S., & Mallhi, T. H. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_14
Considerations in Result Interpretation and Reporting for Microbiome Analysis
Craney, A. R. (2025) · Wiley eBooks · doi:10.1002/9781683674597.ch30
GeXplore : développement d'une approche génomique pour étudier les interactions hôte- pathogène
Kambarev, S. (2016) · theses.fr (ABES) · doi:10.70675/888b7f4bz34e3z48baz8f27z07164850c7fb
Apport de l'ADN circulant tumoral dans les cancers digestifs
Evrard, C. (2022) · theses.fr (ABES) · doi:10.70675/e887f785zd2daz4c33za83fzd8d4cd2f9935
Helicobacter pylori promotes gastric cancer progression through the GATA3-AS1/miR-30c-5p/CTHRC1 axis
Ma, M., ZHANG, C., Yu, K., Wang, H., & Li, Y. M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116850
Yamashita, T., Yoshida, K., Adachi, M. M., Otsuki, T., & Fukuchi, T. (2026) · Case Reports in Infectious Diseases · doi:10.1155/crdi/2798487
Early-onset Neonatal Sepsis and Meningitis Caused by Streptococcus gallolyticus subsp. pasteurianus
Jones, A. K., & Bullinger, S. A. (2026) · Journal of Clinical Neonatology · doi:10.4103/jcn.jcn_48_26
Metadata
- Authors
- Boleij, A., & Tjalsma, H.
- Affiliations
- Johns Hopkins University (US)
- Radboud University Nijmegen (NL)
- ORCID
- Boleij, Annemarie
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 13
- Issue
- 8
- Pages
- 719-724
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2109510012
- Cited by
- 158
- References
- 78
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 12 · 2023: 16 · 2022: 14 · 2021: 9 · 2020: 13 · 2019: 15 · 2018: 9 · 2017: 16 · 2016: 11 · 2015: 10 · 2014: 14 · 2013: 1
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- colorectal cancer, opportunistic infections, virulence factors, gut dysbiosis, gut microbiota, colorectal cancer detection, infection route, host-pathogen interaction
- MeSH terms
- Adenoma, Carcinoma, Endocarditis, Humans, Streptococcal Infections, Colorectal Neoplasms, Streptococcus bovis, Bacterial Translocation, Virulence Factors, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
